产品名称 | Seraseq® 22q11 Female-Matched Reference Material (SeraCare) |
---|---|
目录号 | 0720-0174 |
别名 | N/A |
外观 | N/A |
分子量 | N/A |
CAS | N/A |
溶解度 | N/A |
存储条件 | N/A |
保存时间 | N/A |
备注1 | N/A |
备注2 | N/A |
目录号 | 规格 | 价格 | 库存状态 | |
0720-0174 | 1 x 1 mL | 咨询客服 | 咨询客服 |
品名:Seraseq® 22q11 Female-Matched Reference Material
货号:0720-0174
品牌:SeraCare
Details
Given the clinical implications, it is extremely critical that NIPT assays report back presence or absence of
aneuploidies in an accurate and consistent manner. Matched maternal-fetal reference materials derived from
pregnant maternal plasma enable accurate assessment of a broad range of NIPT assays, including those based
on counting methods, SNPs, as well as differences in the length of maternal and fetal cfDNA.
The Seraseq 22q11 Female Matched Reference Material can be used to develop a new test, validate an assay,
monitor routine performance, troubleshoot problems across the entire workflow and ensure overall proficiency
with the same sustainable product
Matched (or related) maternal-fetal 22q11 (or DiGeorge Syndrome) female sample compatible with a broad range
of NIPT assay methods Proprietary method
maintains native cfDNA characteristics such as size profile of ~170 bp, size distribution, SNP content and natural
maternal-fetal size difference
Offered in a plasma format capable of assessing the entire workflow from extraction through analysis
(identical to clinical samples)
Long shelf-life and lot-to-lot consistency with high quality materials manufactured in GMP-compliant and ISO
13485-certified facilities under strick quality checks
Customization of fetal fraction, concentration, and material formulation (either in plasma or fragmented DNA in
buffer format) available on request/li>
维百奥生物代理SeraCare对照及参比物质。
维百奥(北京)生物科技有限公司,自2018年与SeraCare(现隶属于LGC Clinical Diagnostics)合作以来,长期为中国客户
提供包括SeraSeq系列参比物质,领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质,可以用于任何
研发阶段,以确保临床基因组学检测结果的准确性。
SeraCare参比物质涵盖的范围:
1)Next Generation Sequencing
2)Sanger Sequencing
3)Real-time PCR and digital PCR (dPCR)
4)Microarray
主要特点
1)Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs,
and RNA fusions
2)Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs
3)Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA
in plasma, and FFPE
4)Manufactured in cGMP-compliant, ISO 13485-certified facilities
5)Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers